Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F et al (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet 390(10100):1211–1259

Article  Google Scholar 

Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA et al (2020) Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 8(6):585–596

Article  Google Scholar 

Narendra D, Blixt J, Hanania NA (eds) (2019) Immunological biomarkers in severe asthma. Seminars in immunology. Elsevier

Wenzel SE (2012) Asthma phenotypes: The evolution from clinical to molecular approaches. Nat Med 18(5):716–725

Article  CAS  PubMed  Google Scholar 

Ma B, Athari SS, Mehrabi Nasab E, Zhao L (2021) PI3K/AKT/mTOR and TLR4/MyD88/NF-κB signaling inhibitors attenuate pathological mechanisms of allergic asthma. Inflammation 44:1895–1907

Article  CAS  PubMed  Google Scholar 

Subramanian H, Hashem T, Bahal D, Kammala AK, Thaxton K, Das R (2021) Ruxolitinib ameliorates airway hyperresponsiveness and lung inflammation in a corticosteroid-resistant murine model of severe asthma. Front Immunol 12:786238

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wenzel SE (2006) Asthma: Defining of the persistent adult phenotypes. The Lancet 368(9537):804–813

Article  CAS  Google Scholar 

Al Heialy S, Ramakrishnan RK, Hamid Q (2022) Recent advances in the immunopathogenesis of severe asthma. J Allergy Clin Immunol 149(2):455–465

Article  CAS  PubMed  Google Scholar 

Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ et al (2014) International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43(2):343–373

Article  CAS  PubMed  Google Scholar 

Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord ID (2019) Inhaled corticosteroid therapy in adult asthma. Time for a new therapeutic dose terminology. Am J Respir Crit Care Med 199(12):1471–1477

Article  CAS  PubMed  Google Scholar 

Barnes PJ (1998) Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol 102(4):531–538

Article  CAS  PubMed  Google Scholar 

Nunes C, Pereira AM, Morais-Almeida M (2017) Asthma costs and social impact. Asthma Res Pract 3:1–11

Article  PubMed  PubMed Central  Google Scholar 

Kim J, Ham J, Kang HR, Bae YS, Kim T, Kim HY (2023) JAK3 inhibitor suppresses multipotent ILC2s and attenuates steroid-resistant asthma. Sci Adv 9(51):eadi3770

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skuljec J, Chmielewski M, Happle C, Habener A, Busse M, Abken H et al (2017) Chimeric antigen receptor-redirected regulatory T cells suppress experimental allergic airway inflammation, a model of asthma. Front Immunol 8:1125

Article  PubMed  PubMed Central  Google Scholar 

June CH, Riddell SR, Schumacher TN (2015) Adoptive cellular therapy: A race to the finish line. Sci Transl Med 7(280):280ps7–ps7

Article  PubMed  Google Scholar 

Mazinani M, Rahbarizadeh F (2023) New cell sources for CAR-based immunotherapy. Biomark Res 11(1):1–27

Article  Google Scholar 

Cohen NR, Brennan PJ, Shay T, Watts GF, Brigl M, Kang J et al (2013) Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat Immunol 14(1):90–99

Article  CAS  PubMed  Google Scholar 

Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI (2012) Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol 12(12):845–857

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brennan PJ, Brigl M, Brenner MB (2013) Invariant natural killer T cells: An innate activation scheme linked to diverse effector functions. Nat Rev Immunol 13(2):101–117

Article  CAS  PubMed  Google Scholar 

Wolf BJ, Choi JE, Exley MA (2018) Novel approaches to exploiting invariant NKT cells in cancer immunotherapy. Front Immunol 9:384

Article  PubMed  PubMed Central  Google Scholar 

Burks J, Olkhanud PB, Berzofsky JA (2022) The role of NKT cells in gastrointestinal cancers. OncoImmunology 11(1):2009666

Article  PubMed  Google Scholar 

Robertson FC, Berzofsky JA, Terabe M (2014) NKT cell networks in the regulation of tumor immunity. Front Immunol 5:543

Article  PubMed  PubMed Central  Google Scholar 

Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25:297–336

Article  CAS  PubMed  Google Scholar 

Terabe M, Berzofsky JA (2014) The immunoregulatory role of type I and type II NKT cells in cancer and other diseases. Cancer Immunol Immunother 63:199–213

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farr AR, Wu W, Choi B, Cavalcoli JD, Laouar Y (2014) CD1d-unrestricted NKT cells are endowed with a hybrid function far superior than that of iNKT cells. Proc Natl Acad Sci 111(35):12841–12846

Article  CAS  PubMed  PubMed Central  Google Scholar 

Look A, Burns D, Tews I, Roghanian A, Mansour S (2023) Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes. Front Immunol 14:1176724

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bollino D, Webb TJ (2017) Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy. Transl Res 187:32–43

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K et al (1997) CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278(5343):1626–1629

Article  CAS  PubMed  Google Scholar 

Borg NA, Wun KS, Kjer-Nielsen L, Wilce MC, Pellicci DG, Koh R et al (2007) CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448(7149):44–49

Article  CAS  PubMed  Google Scholar 

Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4(12):1230–1237

Article  CAS  PubMed  Google Scholar 

Victor JR, Lezmi G, Leite-de-Moraes M (2020) New insights into asthma inflammation: Focus on iNKT, MAIT, and γδT cells. Clin Rev Allergy Immunol 59:371–381

Article  CAS  PubMed  Google Scholar 

Lisbonne M, Diem S, de Castro KA, Lefort J, Araujo LM, Hachem P et al (2003) Cutting edge: Invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 171(4):1637–1641

Article  CAS  PubMed  Google Scholar 

Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T et al (2003) Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med